HighVista Strategies »

Tango Therapeutics shares owned by HighVista Strategies

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 104k 20.92

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Tango Therapeutics

Rtw Investments
Adage Capital Partners GP
Boxer Capital Management
TCG Crossover Management
FMR
Farallon Capital Management
BlackRock
Woodline Partners
Nextech Invest
Vanguard Group
Trv Gp Iv
Siren
Vanguard Capital Management
Goldman Sachs Group
State Street Corporation

View all funds holding Tango Therapeutics